With the annual flu season about to start, it's still unclear exactly how influenza virus will…
emcguinnSeptember 4, 2020
The DNA of all organisms, be it bacteria or humans, is constantly bombarded with damage…
emcguinnSeptember 2, 2020
RareCyte® announces a new dual biomarker liquid biopsy assay for androgen receptor splice variant 7 (ARv7)…
emcguinnSeptember 1, 2020
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), achieved the on-schedule…
emcguinnAugust 31, 2020
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19…
emcguinnAugust 31, 2020
Silverback Therapeutics (“Silverback”), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered but…
emcguinnAugust 28, 2020
A Phase 1 patient trial of the novel, oral therapy candidate, alpha-TEA, for advanced HER2 positive breast cancer is…
emcguinnAugust 28, 2020
Scientists have demonstrated a new way to precisely target cells by distinguishing them from neighboring…
emcguinnAugust 26, 2020
Last week the National Cancer Institute released some good news for patients with lung cancer: improved…
emcguinnAugust 26, 2020
